NASDAQ
AVAH
Last Price
US $11.29
KEY FIGURES
MKT CAP
$2.5B
EPS
TTM
$1.26
EPS Growth (1Y)
-1951.85%
PEG
TTM
-
P/E
TTM
8.95x
P/S
TTM
0.94x
YIELD
-
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Aveanna Healthcare Holdings Inc. cash flow to debt ratio of 8.07% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Aveanna Healthcare Holdings Inc. has insufficient data to evaluate this check.
Debt-to-equity ratio
Aveanna Healthcare Holdings Inc.'s debt to equity ratio is 6.26, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Aveanna Healthcare Holdings Inc. has insufficient data to evaluate this check.
Net debt to EBITDA
Aveanna Healthcare Holdings Inc. has a net debt to EBITDA ratio of 4.81x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
Aveanna Healthcare Holdings Inc.'s interest coverage ratio of 2.18 indicates that earnings with margin can cover interest payments on company debt
Profit margin growth
Aveanna Healthcare Holdings Inc.'s profit margin has increased (-2.02K%) in the last year from -0.54% to 10.37%, signaling increasing performance
Current ratio
Aveanna Healthcare Holdings Inc.'s short-term assets of $560.23M exceed its short-term liabilities of $424.46M
Return on assets
Aveanna Healthcare Holdings Inc.'s return on assets of 12.93% is higher than the 5.00% threshold, indicating efficient asset utilization
Return on equity
Aveanna Healthcare Holdings Inc.'s return on equity of 241.47%, is higher than 15.00%, indicating good performance
Earnings quality
Aveanna Healthcare Holdings Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Aveanna Healthcare Holdings Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings
Positive free cash flow
Aveanna Healthcare Holdings Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Aveanna Healthcare Holdings Inc. has a free cash flow yield of 5.57%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
Aveanna Healthcare Holdings Inc.'s yearly earnings has increased -2.16K% since last year from $-10.93M to $225.03M, signaling increasing performance
Revenue growth
Aveanna Healthcare Holdings Inc. has insufficient data to evaluate this check.
Return on invested capital
ROIC 15.86% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
3-year revenue CAGR
Aveanna Healthcare Holdings Inc.'s 3-year revenue CAGR of 10.82% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Aveanna Healthcare Holdings Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Aveanna Healthcare Holdings Inc. has insufficient net-income and equity history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Aveanna Healthcare Holdings Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Aveanna Healthcare Holdings Inc. has an earnings yield of 12.88%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
EBITDA Valuation
Aveanna Healthcare Holdings Inc. is overvalued relative to its fair value price of 3.55 based on EBITDA multiple model
EV/EBITDA (FY)
Aveanna Healthcare Holdings Inc. has an EV/EBITDA ratio of 12.31x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
Aveanna Healthcare Holdings Inc. had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.
Price-to-book ratio (FY)
Aveanna Healthcare Holdings Inc. has a price-to-book ratio of 8.43x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
Aveanna Healthcare Holdings Inc. has a price-to-sales ratio of 0.80x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
150.20%
Return on equity
ROIC: 16.78%
Valuation History
8.5X
Price to Earnings
EV/EBITDA: 12.4X
Cash flow
Profit margin
8.46%
EBITDA
28.33%
Cash flow
-
Cash Flow (DCF)
Fair Value
Market $11.29
—
Default assumptions
EBITDA Multiple
Fair Value
Market $11.29
-68.56%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.